Skip to main content

Table 2 Comparative product quality (target fraction; mean ± SEM)

From: Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure

  CliniMACS Prodigy t test
T-cells/4 × 106 CD34+ 926 ± 213 4989 ± 2425 0.171
B-cells/4 × 106 CD34+ 2012 ± 1512 7711 ± 6664 0.013
Recovery CD34+ 61 ± 5 58 ± 5 0.736
B-cell depletion 9.30−5 ± 1.51−5 3.52−4 ± 6.27−5 0.016
T-cell depletion 1.32−5 ± 1.95−6 5.78−5 ± 8.63−6 0.007
\